study_name	subject_id	Sample Source ID	target_condition	target_condition_ontology_term_id	control	control_ontology_term_id	country	country_ontology_term_id	body_site	body_site_ontology_term_id	age_group	age_group_ontology_term_id	age_max	age_min	age_years	antibiotics_current_use	biomarker_name	biomarker_unit	biomarker_value	bmi	curator	disease	disease_ontology_term_id	median_read_length	minimum_read_length	ncbi_accession	number_bases	number_reads	pmid	sequencing_platform	sex	sex_ontology_term_id	treatment	treatment_ontology_term_id	westernized	package	last_updated
KarlssonFH_2013	S118	S118	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	12.3;1.53153;212.2969824;74;108.38;0.7;95.4954;72.6;20.1847446504;2.16;0;57.86293466448;23;1.8;522.14;47.85447338692	32.7	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260250	3307295096	32745496	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S126	S126	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.6;1.5015;257.9272992;63;100.46;0.1;81.081;81.4;40.66852255488;0.39;0;52.330819464;4.75;0.7;806.45;77.66545680828	18.6	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260252	2981401426	29518826	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S127	S127	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	11.7;3.42342;235.4988384;114;113.5134;79.2;20.9323277856;0.68;62.34843347568;25.4;0.7;90.2174498278	26.6	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260253	2480018034	24554634	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S131	S131	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	7;5.34534;181.747872;71;147.82;1.4;102.7026;83.6;15.6992458392;26.51;0;41.8646555712;29.6;0.2;1107.28;148.27041754308	26.5	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260254	2607637392	25818192	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S137	S137	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	17.4;2.16216;294.6635712;58;122.88;0.3;90.09;79.2;33.04317457584;0.82;0;74.60879689296;11.3;0.8;637.54;72.17395986224	23.2	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	96	96	ERR260268	797799936	8310416	23719380	IlluminaHiSeq	Female	NCIT:C16576	Not applicable		Yes	cMD	10:43.0
KarlssonFH_2013	S144	S144	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	16.4;1.92192;237.4323264;94;91.32;0.9;104.5044;83.6;29.903325408;1.27;0;55.02211875072;14.5;0.7;810.44;79.23445593572	24	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260257	4552459456	45073856	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S146	S146	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	21.1;1.68168;250.1933472;72;85.29;0.1;81.081;81.4;20.48377790448;7.68;0;68.47861518432;42.6;0.4;918.41;91.78644895524	36.9	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260258	2389231154	23655754	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S153	S153	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	27.6;1.47147;266.0479488;63;66.99;0.4;100.9008;81.4;37.82770664112;1.5;0;62.19891684864;6.16;0.5;639.78;32.94898167624	21.6	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260259	3929291476	38903876	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S155	S155	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	France	NCIT:C16592	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	16.5;2.1021;215.0038656;62;131.88;0.3;90.09;81.4;35.1364073544;0.6;0;42.31320545232;8.49;0;476.37;65.11346378876	21.5	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260260	3874689260	38363260	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S158	S158	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	68	68	68	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.5;8.1081;203.4029376;97;56.02;4.8;198.198;116.6;28.55767576464;6.48;0;40.07045604672;33.4;0.4;1073.95;117.674934558	31.2	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260261	4053706508	40135708	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S186	S186	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	20.1;1.65165;204.5630304;52;172.68;1.4;100.9008;88;33.19269120288;0.51;0;41.8646555712;11.4;0.2;608.62;47.0699738232	23.6	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260262	2995481028	29658228	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S187	S187	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.1;2.1021;245.552976;85;73.53;0.3;95.4954;79.2;26.01589310496;2.26;0;60.85326720528;28.5;0.2;817.84;92.57094851896	24.6	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260263	4562815390	45176390	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S193	S193	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.7;2.49249;251.7401376;56;97.98;0.1;104.5044;88;34.3888242192;0.71;0;51.5832363288;11.5;0.3;603.82;131.79592670496	24.2	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260264	4952644484	49036084	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S195	S195	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.4;1.86186;203.01624;71;111.89;3.4;90.09;77;19.73619476928;3.84;0;49.78903680432;27;0.1;657.49;103.55394241104	28.4	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260266	3926410956	38875356	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S198	S198	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	17.1;2.61261;240.9126048;72;103.25;0.9;120.7206;77;33.34220782992;3;0;52.77936934512;18.8;0.3;1033.03;80.01895549944	26.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260267	4078647852	40382652	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S225	S225	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11;2.43243;248.6465568;65;58.24;0.2;113.5134;79.2;31.3984916784;13.56;0;60.10568407008;14.8;0.3;389.8;54.13046989668	26.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260231	2099276314	20784914	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S227	S227	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.7;1.74174;237.819024;68;297.92;1.7;104.5044;79.2;33.641241084;1.15;0;52.77936934512;30.3;0.9;766.81;65.89796335248	24	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260232	1885347204	18666804	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S229	S229	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.28;2.94294;254.4470208;64;69.8;0.1;86.4864;77;23.02556056416;5.67;0;65.7873158976;28.4;0.4;989.69;111.39893804824	27.4	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260233	2088164698	20674898	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S231	S231	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.8;2.25225;235.885536;64;65.28;0.8;88.2882;68.2;27.21202612128;1.49;0;55.91921851296;21.7;0.2;592.01;94.1399476464	25.7	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260234	2482589292	24580092	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S239	S239	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	16.8;2.52252;257.153904;65;91.03;1.8;95.4954;72.6;18.09151187184;1.36;0;68.32909855728;16.1;56.6;699.12;152.9774149254	25.1	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260236	2035785088	20156288	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S243	S243	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.2;2.34234;206.883216;69;125.85;1.4;111.7116;74.8;35.1364073544;4.11;0;37.22964013296;35.2;1.3;458.06;90.2174498278	26.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260237	2745456134	27182734	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S244	S244	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	10;6.006;274.555296;65;218.0178;114.4;15.84876246624;4.64;65.7873158976;40.3;0.6;285.55784119408	32.8	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260238	2836099796	28080196	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S248	S248	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	6.85;2.4024;206.4965184;64;91.9;1.5;131.5314;105.6;28.10912588352;2.88;0;43.3598218416;48.2;1.6;856.49;98.84694502872	31.3	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260239	2577105900	25515900	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S264	S264	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	30.2;1.62162;208.4300064;72;146.48;1.1;90.09;81.4;31.69752493248;0.63;0;43.3598218416;14.7;0.2;522.79;65.11346378876	24	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260242	1601761828	15859028	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S268	S268	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.7;1.77177;247.486464;69;75.4;0.1;106.3062;81.4;29.00622564576;0.94;0;60.40471732416;7.33;0.6;552.14;72.95845942596	25.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260243	2297022396	22742796	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S269	S269	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	13.1;1.83183;221.5777248;58;149.89;0.1;106.3062;74.8;37.22964013296;1.12;0;42.31320545232;39.4;0;766.32;72.95845942596	32.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260244	1939606828	19204028	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S278	S278	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Norway	NCIT:C16920	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.1;2.43243;259.8607872;64;90.97;0.8;95.4954;79.2;27.36154274832;7.05;0;68.32909855728;44.9;0.6;745.27;55.69946902412	33.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260245	2711037556	26841956	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S288	S288	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	20.5;1.89189;170.146944;59;114.86;0.8;120.7206;77;20.63329453152;1.24;0;37.52867338704;8.53;0.1;602.49;89.43295026408	26.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260246	2489746758	24650958	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S290	S290	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.1;2.67267;220.8043296;77;455.48;0.9;109.9098;92.4;21.97894417488;1.26;0;47.69580402576;20.1;0.4;702.19;183.57289791048	23.8	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260247	2351107088	23278288	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S297	S297	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.1;2.22222;272.621808;65;50.89;0.1;108.108;77;30.20235866208;1.54;0;69.37571494656;10.9;0.1;765.46;66.6824629162	22	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260271	761805504	7935474	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S305	S305	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	20.7;1.83183;242.8460928;54;202.04;1.6;102.7026;90.2;26.31492635904;0.13;4.64;58.46100117264;7.01;0.8;617.9;106.69194066592	21.5	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260133	2664136590	26377590	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S312	S312	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	23.3;2.13213;203.01624;73;79.48;0.4;122.5224;79.2;34.98689072736;3.14;0;37.22964013296;36;0.9;688.31;72.95845942596	26.7	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260134	14947398242	147994042	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S317	S317	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	13.2;2.52252;221.5777248;92;260.83;0.1;108.108;83.6;36.78109025184;0.83;0;45.15402136608;28;0.1;501.25;42.36297644088	26	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260135	13981314860	138428860	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S327	S327	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.6;2.31231;249.419952;76;77.77;0;91.8918;74.8;34.98689072736;0.49;0;54.5735688696;38.5;2;889.07;80.80345506316	30.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260136	2589449312	25638112	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S342	S342	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	20.6;2.13213;225.0580032;67;125.01;0.5;115.3152;81.4;31.99655818656;0.69;0;49.78903680432;6.21;0;564.43;61.19096597016	22.3	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	96	96	ERR260272	789010752	8218862	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S344	S344	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	6.75;5.52552;225.8313984;85;138.55;0.6;84.6846;79.2;17.79247861776;11.37;2.41;59.20858430784;105;0.5;1004;120.81293281288	41.8	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260140	1935856900	19166900	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S347	S347	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	13;2.22222;201.082752;63;202.14;1;97.2972;72.6;31.54800830544;0.69;0.85;39.6219061656;22.5;0;941.35;74.5274585534	24.7	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260141	2488603034	24639634	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S349	S349	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.36;1.74174;174.4006176;48;215.11;0.6;97.2972;59.4;27.95960925648;10.06;0;34.98689072736;7.06;0.1;816.53;53.34597033296	19.6	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260142	2452610674	24283274	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S350	S350	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	12.9;2.07207;212.2969824;61;52.1;0.9;97.2972;101.2;32.29559144064;0.42;0;42.91127196048;23.3;0.2;559.14;80.01895549944	28.2	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260143	2849144956	28209356	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S356	S356	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.13;2.79279;287.7030144;81;61.97;4;73.8738;83.6;29.00622564576;4.48;1.73;71.16991447104;28.9;1.5;901.82;131.01142714124	27.1	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260146	2805316612	27775412	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S365	S365	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	16.8;1.56156;218.8708416;72;142.31;1.5;104.5044;88;35.73447386256;1.18;0;42.76175533344;23.3;0.8;655.19;71.38946029852	24.8	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260147	2821768300	27938300	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S367	S367	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Slovakia	NCIT:C17669	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	7.81;4.56456;253.286928;60;70.2702;83.6;12.11084679024;21;43.06078858752;42.1;0.9;498.1572229622	32.3	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260148	2209859194	21879794	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S372	S372	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.5;3.003;288.4764096;132;253.72;0.7;104.5044;92.4;28.85670901872;13.2;0.55;72.21653086032;91.8;0.9;1007.16;121.5974323766	39.7	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260150	3043333010	30132010	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S378	S378	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	21.3;1.2012;216.9373536;54;57.14;0.3;109.9098;99;26.61395961312;0.9;9.54;50.38710331248;5.47;0.5;568;79.23445593572	21.4	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260151	2630431274	26043874	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S381	S381	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	19.2;1.77177;270.68832;74;97.35;3.8;73.8738;74.8;18.54006175296;1.47;0;77.7486460608;16.2;0.4;1216.26;98.062445465	25.8	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260153	2811341262	27835062	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S389	S389	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.55;3.21321;196.0556832;70;30.76;1.4;140.5404;112.2;23.1750771912;0.65;0;46.64918763648;35;1.5;1246.62;69.03596160736	27.1	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260155	2575030956	25495356	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S393	S393	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.4;3.54354;222.35112;85;311.24;3;95.4954;83.6;15.54972921216;2.84;3.82;47.0977375176;26;0.4;861.83;271.43684904712	29.5	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260156	1683913006	16672406	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S395	S395	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.53;2.67267;248.2598592;66;56.69;0.6;100.9008;77;22.427494056;0.41;0;65.18924938944;19.6;2.3;811;97.27794590128	30.4	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260157	2355739554	23324154	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S397	S397	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	7.67;2.16216;209.2034016;67;59.85;0.6;93.6936;79.2;16.4468289744;10.87;0;57.5639014104;18.2;0.4;865.49;78.449956372	27.4	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260158	2106879392	20860192	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S420	S420	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	21.6;2.01201;270.3016224;73;109.15;0.1;99.099;81.4;26.165409732;2.37;0;71.46894772512;10.9;0.5;771.32;79.23445593572	25.6	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260160	2333460974	23103574	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S421	S421	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.2;3.36336;178.2675936;56;63.05;1.3;122.5224;105.6;21.23136103968;7.5;0;41.41610569008;49.9;0.4;109.75;73.74295898968	44.6	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260161	4332127956	42892356	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S424	S424	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.78;4.41441;232.4052576;69;782.18;4.5;104.5044;90.2;24.52072683456;2.53;0;54.27453561552;77.7;2.5;1312.23;128.65792845008	35.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260163	3218523570	31866570	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S434	S434	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.3;2.31231;243.619488;64;374.99;0.4;136.9368;77;23.32459381824;2.23;0;60.25520069712;13.1;0.7;873.32;123.95093106776	25.8	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260165	4665993960	46197960	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S441	S441	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.8;2.94294;235.885536;70;102.69;0.9;106.3062;88;21.38087766672;2;9.56;61.3018170864;29.7;0.1;727.64;99.63144459244	27.5	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260168	4677011242	46307042	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S451	S451	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	13.1;0.93093;143.8515072;58;61.66;1.7;86.4864;88;26.76347624016;0.77;0;25.56734322384;2.17;0.3;660.47;38.44047862228	20.4	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260170	3060202838	30299038	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S456	S456	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	26.3;1.92192;247.0997664;54;155.23;0.1;84.6846;72.6;37.82770664112;0.9;0;53.37743585328;6.98;1.1;559.32;49.42347251436	23.7	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260171	5829033604	57713204	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S462	S462	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.1;3.21321;209.5900992;57;99.42;1.1;129.7296;92.4;18.24102849888;0.69;0.82;55.17163537776;25.6;0;556.64;89.43295026408	29.4	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260174	4557287054	45121654	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S468	S468	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Hungary	NCIT:C16699	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.2;1.83183;208.0433088;47;123.71;4.8;133.3332;114.4;28.85670901872;2.38;0;48.29387053392;13;0.3;552.25;38.44047862228	33.7	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260176	3742755384	37056984	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S470	S470	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.2;2.1021;212.2969824;60;80.72;0.5;117.117;88;30.05284203504;0.34;12.89;48.29387053392;10.4;0.3;332.07;43.1474760046	23.7	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260273	820824384	8550254	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S472	S472	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	12.7;2.97297;199.149264;72;71.51;0.5;99.099;57.2;25.71685985088;2.52;0;40.66852255488;35.8;0;711.86;122.38193194032	33.3	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260177	4335598114	42926714	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S475	S475	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Denmark	NCIT:C16496	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.11;1.38138;205.3364256;59;54.88;1.6;154.9548;99;25.4178265968;0.69;0;48.74242041504;7.11;0.8;651.95;61.97546553388	23	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260274	1145858688	11936028	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S484	S484	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	6.48;4.14414;227.3781888;93;59.25;4.5;115.3152;112.2;19.4371615152;1.21;0;56.66680164816;29.1;1;1079.71;138.07192321472	30.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260182	4418154706	43744106	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S487	S487	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.9;1.62162;172.8538272;61;544.12;2.2;86.4864;79.2;24.81976008864;99.22;0;37.08012350592;3.59;0.3;465.58;57.26846815156	21.2	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260183	4621291764	45755364	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S488	S488	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	21.8;1.62162;208.4300064;70;140.3;0.2;91.8918;96.8;24.6702434616;1.46;0;50.8356531936;7.28;0.5;356.51;58.837467279	19.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260184	4346089994	43030594	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S495	S495	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Estonia	NCIT:C16562	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.52;3.9039;336.8136096;49;228.33;1.8;124.3242;88;28.70719239168;2.23;1.44;87.4672268184;16.5;0;688.48;164.7449083812	29.1	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260185	4266979118	42247318	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S517	S517	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.91;2.52252;209.2034016;75;172.73;0.7;99.099;101.2;23.02556056416;2.62;0;48.74242041504;25.1;0.3;704.4;107.47644022964	27.5	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260188	4182939644	41415244	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S526	S526	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	17.7;2.1021;182.1345696;59;521.85;5.9;113.5134;79.2;33.34220782992;1.36;0;31.69752493248;14.6;0.2;510.36;62.7599650976	26.1	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260190	4142624080	41016080	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S53	S53	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	12;1.5015;207.6566112;76;75.6756;83.6;24.37121020752;1.25;48.89193704208;5.28;0.7;80.80345506316	21.3	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260193	2822317336	27943736	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S543	S543	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.5;3.6036;177.880896;59;137.13;1.3;129.7296;96.8;28.10912588352;7.93;0;33.79075771104;31.8;0.4;1203.67;80.80345506316	27.6	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260196	4253796800	42116800	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S547	S547	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	7.3;2.64264;216.1639584;64;86.4864;83.6;24.22169358048;0.64;51.43371970176;20.6;0.2;94.1399476464	24.3	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260197	4151530058	41104258	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S551	S551	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	18.3;2.85285;233.1786528;72;73.08;2.1;129.7296;96.8;49.3404869232;1.62;0;34.3888242192;5.49;0.3;901.43;76.09645768084	21.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260198	4760622880	47134880	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S552	S552	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.1;2.49249;206.4965184;50;113.79;0.1;108.108;90.2;32.59462469472;5.21;0;42.46272207936;12.2;1.2;889.54;54.9149694604	19.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260199	3032782146	30027546	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S558	S558	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	18.8;2.13213;205.3364256;58;131.5314;74.8;38.27625652224;1.1;35.8839904896;22.9;0.2;61.97546553388	25.5	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260200	3556340694	35211294	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S561	S561	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	16.3;3.96396;152.745552;74;315.21;4.5;79.2792;83.6;4.4854988112;27.15;2.23;42.91127196048;10.3;0.2;2276.46;136.50292408728	21.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260201	4322020280	42792280	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S58	S58	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Iceland	NCIT:C16704	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.7;2.55255;213.0703776;69;56.47;1.2;77;27.81009262944;13.16;0;47.39677077168;44;0.1;1184.81;84.72595288176	31.9	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260204	2669086600	26426600	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S584	S584	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	11.9;1.89189;228.5382816;89;84.6846;70.4;30.94994179728;1.86;49.04145366912;5.6;1.7;96.49344633756	21.6	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260205	3029874356	29998756	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S589	S589	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	3.68;4.14414;264.1144608;75;109.28;17.8;138.7386;107.8;18.83909500704;3.54;0;69.67474820064;31.4;0.3;1169.62;157.68441230772	29	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260207	3170606746	31392146	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S591	S591	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.5;2.76276;191.0286144;77;199.62;3.1;100.9008;81.4;30.05284203504;1.81;0.63;36.48205699776;21.2;0.5;434.41;85.51045244548	25	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260208	3833173412	37952212	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S60	S60	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	7.34;2.79279;211.9102848;53;99.15;0.1;100.9008;88;23.62362707232;4.55;0;53.37743585328;49.4;0.3;966.14;57.26846815156	27.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR275251	3014779704	29849304	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S604	S604	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Slovakia	NCIT:C17669	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.7;7.8078;271.0750176;90;253.37;16;297.297;129.8;18.98861163408;6.25;0;63.84359974608;36.4;0.5;1348.58;257.31585690016	28.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260214	3923443172	38845972	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	10:43.0
KarlssonFH_2013	S614	S614	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	28;1.92192;260.6341824;66;158.25;1.7;95.4954;77;39.17335628448;0.94;0;55.3211520048;12.5;0.4;1224.79;71.38946029852	20.6	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260215	1545961348	15306548	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S617	S617	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.8;2.19219;226.218096;76;168.9;1.4;106.3062;81.4;22.87604393712;2.04;6;58.3114845456;15.4;0.2;655.61;72.17395986224	23.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260216	979554560	9698560	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S618	S618	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.8;1.98198;221.5777248;59;54.27;0.9;93.6936;72.6;25.56734322384;1.09;0;52.330819464;12.5;0.1;333.52;90.2174498278	21.8	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260217	1699498114	16826714	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S628	S628	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.9;1.59159;235.1121408;44;67.19;0.3;95.4954;74.8;34.98689072736;14.92;0.63;51.28420307472;21.3;0.9;913.25;53.34597033296	25.8	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260218	1397757180	13839180	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S638	S638	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.5;1.65165;257.153904;60;306.87;0.1;104.5044;77;41.71513894416;1.26;2.05;53.37743585328;8.12;0.5;690.95;49.42347251436	22.4	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260219	1153977722	11425522	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S643	S643	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	34.8;1.53153;202.6295424;59;220.89;0.1;106.3062;79.2;30.80042517024;2.77;0;42.76175533344;10.1;0.2;867.17;55.69946902412	27.4	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260221	1546072246	15307646	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S646	S646	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	7.49;3.75375;170.5336416;64;188.26;1.5;102.7026;77;12.85842992544;2.4;0;39.32287291152;23.4;0.3;585.88;160.03791099888	31.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260222	1435723080	14215080	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S77	S77	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	24.8;2.43243;241.2993024;63;72;0.1;99.099;94.6;26.01589310496;1.69;0.6;63.544566492;28.5;0.5;1006.04;43.1474760046	33.2	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260224	2765273748	27378948	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S88	S88	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	19;1.74174;214.617168;63;102.7026;83.6;32.8936579488;2.98;44.854988112;7.14;0.2;61.19096597016	21.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260226	2757221826	27299226	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S92	S92	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	17.8;2.16216;235.885536;70;90.09;83.6;28.4081591376;1.02;55.76970188592;14.7;0.9;80.80345506316	22.6	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260227	2215989086	21940486	23719380	IlluminaHiSeq	Female	NCIT:C16576		NCIT:C41132	Yes	cMD	10:43.0
KarlssonFH_2013	S112	S112	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	22.2;1.83183;202.2428448;65;115.77;0.1;142.3422;79.2;38.27625652224;1.15;0;31.69752493248;12.2;0;932.26;95.70894677384	24.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260249	1954234860	19348860	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S121	S121	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	12.2;2.7027;200.3093568;68;156.83;0.8;106.3062;79.2;42.16368882528;1.13;0;31.54800830544;72.1;0.1;767.02;43.1474760046	29.7	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260251	2503143600	24783600	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S141	S141	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	21.4;1.32132;186.7749408;75;33.33;0.8;82.8828;77;38.27625652224;1.9;0;29.45477552688;8.96;0.3;710.69;52.56147076924	25.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260255	1999859186	19800586	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S143	S143	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	12.3;2.37237;233.5653504;71;172.94;0.1;88.2882;81.4;33.94027433808;0.56;0;47.0977375176;22.9;0.2;814.43;106.69194066592	28.8	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260256	3014347020	29845020	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S194	S194	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.4;2.82282;160.479504;80;73.58;1.4;102.7026;83.6;26.61395961312;0.21;0;29.30525889984;15.1;0;807.93;70.6049607348	21.9	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260265	4448436324	44043924	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S200	S200	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.65;2.82282;197.215776;71;87.99;0.1;104.5044;90.2;19.88571139632;1.52;0.26;42.31320545232;23.4;0.1;690.19;163.17590925376	29.2	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260228	3848483598	38103798	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S205	S205	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.6;2.73273;169.3735488;97;68.8;3.6;149.5494;129.8;23.32459381824;1.28;0;32.1460748136;23.2;0.6;676.39;117.674934558	24.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260229	2900968460	28722460	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin	NCIT:C61612;CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S224	S224	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11;2.1021;136.5042528;74;49.67;1.7;102.7026;81.4;19.13812826112;7.03;0;27.21202612128;17.1;0.6;715.62;75.31195811712	26.5	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260230	1996491240	19767240	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin,Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S235	S235	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.59;4.05405;194.1221952;110;70.38;2;201.8016;167.2;17.9419952448;1.34;0;30.35187528912;57.5;0.8;641.53;313.799825488	36.4	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260235	1521783362	15067162	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin,Therapeutic Insulin	NCIT:C61612;CHEBI:87631;NCIT:C2271	Yes	cMD	10:43.0
KarlssonFH_2013	S249	S249	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	13.5;2.91291;182.9079648;62;76.69;1.3;88.2882;99;29.903325408;1.38;0;36.18302374368;14.6;0.6;704.67;54.13046989668	23.1	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	96	96	ERR260269	966913152	10072012	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S258	S258	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.5;6.006;162.0262944;60;158.27;7.5;147.7476;92.4;17.04489548256;1.55;0;32.1460748136;45.2;0.1;767.49;157.68441230772	34.2	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260240	2673502926	26470326	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin	NCIT:C61612;CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S263	S263	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	16.2;1.68168;158.9327136;65;123.56;0.1;93.6936;96.8;27.6605760024;1.44;0;27.21202612128;8.79;0.4;635.58;76.88095724456	25.1	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260241	2339488654	23163254	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S286	S286	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Denmark	NCIT:C16496	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.34;2.37237;185.614848;54;36.12;0.7;192.7926;101.2;28.55767576464;0.82;0;36.78109025184;19.1;0;683.31;73.74295898968	23	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260270	1061488704	11057174	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin	NCIT:C61612;CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S299	S299	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.9;3.54354;271.0750176;70;172.12;11.2;82.8828;88;21.23136103968;0.67;0;71.91749760624;19.9;1;839.61;135.71842452356	26.1	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260248	2282760388	22601588	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S304	S304	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	15.5;2.04204;164.34648;57;102.7026;92.4;23.1750771912;0.49;34.3888242192;21.1;3;70.6049607348	29.1	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260132	2756179910	27288910	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S330	S330	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.3;2.76276;173.2405248;182;98.57;0.5;106.3062;74.8;32.59462469472;2.26;0;27.06250949424;37.6;0.1;894.24;85.51045244548	29.6	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260137	1942446342	19232142	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S332	S332	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	24.6;4.05405;250.5800448;112;344.52;1.1;124.3242;83.6;42.6122387064;5.68;0;47.8453206528;57.1;0.1;894.44;74.5274585534	29.2	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260138	3430913238	33969438	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S334	S334	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.54;3.66366;147.7184832;59;82.53;1.3;120.7206;72.6;20.1847446504;1.07;0;27.95960925648;7.02;4.7;276.65;105.9074411022	25.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260139	2036676514	20165114	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S353	S353	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	26.6;3.24324;218.484144;78;130.04;2.7;176.5764;103.4;21.53039429376;2.35;6.4;56.06873514;36.3;0.6;703.12;80.01895549944	29.1	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260144	2483902494	24593094	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S354	S354	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Slovakia	NCIT:C17669	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	9.67;3.09309;224.284608;58;109.9098;81.4;21.97894417488;0.85;53.8259857344;31.7;0.7;127.87342888636	32.9	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260145	2832133728	28040928	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S370	S370	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	7.46;8.4084;195.282288;95;110.08;13.1;158.5584;127.6;15.10117933104;3.26;0.1;50.8356531936;37.5;0.8;1218.49;97.27794590128	28	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260149	3081799264	30512864	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin	NCIT:C61612;CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S380	S380	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.84;4.2042;169.7602464;69;160.61;0.7;117.117;107.8;15.84876246624;1.84;0;33.79075771104;36;0.9;677.67;185.14189703792	30.6	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260152	1813559434	17956034	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S384	S384	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	5.64;4.8048;161.2528992;72;206.06;0;138.7386;94.6;14.2040795688;1.32;7.29;33.79075771104;49.1;0.9;1231.77;168.6674061998	32.8	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260154	2485331038	24607238	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S398	S398	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.9;3.75375;189.481824;72;97.11;1.9;100.9008;96.8;29.903325408;2.28;0;36.6315736248;33.8;0.9;763.23;77.66545680828	24.8	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260159	2187599400	21659400	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S422	S422	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.45;1.89189;135.34416;60;107.27;0.9;156.7566;114.4;23.32459381824;3.48;11.91;21.82942754784;21.6;0;804.95;83.15695375432	25.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260162	6206585340	61451340	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S432	S432	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.1;3.42342;255.220416;71;100.73;1.2;97.2972;81.4;19.4371615152;3.2;2.73;61.89988359456;37.8;0.3;1179.49;203.18538700348	27.8	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260164	3528416012	34934812	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S436	S436	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	19.6;1.68168;227.3781888;81;86.25;0.2;99.099;83.6;43.06078858752;11.82;0;39.02383965744;18.5;1.5;1192.01;67.46696247992	27.2	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260166	4395895316	43523716	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S439	S439	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.2;3.63363;145.0116;69;49.3;2.5;100.9008;83.6;27.6605760024;0.85;16.85;24.22169358048;32.9;0.2;673.58;50.9924716418	31.8	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260167	4349189684	43061284	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S446	S446	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	68	68	68	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15;2.91291;174.4006176;57;119.19;0.6;158.5584;99;21.53039429376;38.95;0;36.33254037072;48.9;0.4;148.95;112.18343761196	31.7	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260169	1920754976	19017376	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S457	S457	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.9;2.13213;190.2552192;64;273.73;0.4;117.117;92.4;22.27797742896;1.21;5.77;42.76175533344;29.5;0;791.41;98.84694502872	28.3	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260172	5463190394	54090994	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S458	S458	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.2;3.21321;209.9767968;60;173.53;4.6;135.135;110;21.23136103968;3.53;0;40.51900592784;29.8;0.4;977.02;225.93587435136	33	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260173	6016218318	59566518	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S463	S463	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	6.1;3.18318;165.5065728;61;48.04;1.2;120.7206;88;20.63329453152;2.48;1.42;32.74414132176;40.4;0.1;523.9;123.16643150404	31	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260175	3201683234	31699834	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S476	S476	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.82;4.08408;143.4648096;55;71.52;8.9;149.5494;101.2;19.88571139632;1.31;3.31;28.55767576464;21.1;1.3;902.35;81.58795462688	30.2	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260178	5173989216	51227616	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin	NCIT:C61612;CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S478	S478	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	12.3;2.04204;146.1716928;55;63.13;0.2;135.135;96.8;24.96927671568;7.64;0;26.46444298608;43.5;0.4;970.13;59.62196684272	36.6	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260179	4220008866	41782266	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S479	S479	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.7;4.11411;221.9644224;74;149.5;1.7;104.5044;92.4;15.84876246624;1.78;0;46.05112112832;25.7;0.5;862.85;279.28184468432	28.8	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260180	3226205832	31942632	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S483	S483	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.87;2.97297;167.0533632;67;219.58;3.1;136.9368;94.6;31.3984916784;1.9;0;25.11879334272;28;1.2;578.9;92.57094851896	23.7	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260181	5014212670	49645670	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S485	S485	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	9.61;3.48348;169.3735488;70;295.9;0.7;104.5044;77;13.15746317952;0.58;0;44.854988112;15.8;0.4;717.03;87.07945157292	23.4	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	96	96	ERR260275	1090824000	11362750	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S497	S497	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.3;2.85285;181.747872;77;176.5;1.1;142.3422;90.2;30.05284203504;0.81;0;37.22964013296;17;0;779.93;34.51798080368	23.8	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260186	4022382974	39825574	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S51	S51	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	15.2;2.1021;221.1910272;72;155.25;1.2;118.9188;77;27.06250949424;0.93;0;43.3598218416;14.1;0.5;254.49;174.15890314584	28.8	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260187	2151950642	21306442	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S524	S524	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	10.7;2.01201;192.1887072;62;76.65;1.9;95.4954;88;26.46444298608;1.37;0;40.21997267376;14.8;0;415.85;88.64845070036	28.5	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260189	3682643416	36461816	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S529	S529	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	4.39;1.95195;132.2505792;81;255.8556;169.4;19.88571139632;3.85;20.33426127744;32.4;0.9;127.08892932264	27.1	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260191	4948806686	48998086	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin,Therapeutic Insulin	NCIT:C61612;CHEBI:87631;NCIT:C2271	Yes	cMD	10:43.0
KarlssonFH_2013	S530	S530	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.8;0.87087;225.4447008;69;255.56;0.1;154.9548;123.2;24.96927671568;1.08;0;57.41438478336;14.1;0;1061.43;55.69946902412	28.1	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260192	3860516334	38222934	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Therapeutic Insulin	NCIT:C61612;NCIT:C2271	Yes	cMD	10:43.0
KarlssonFH_2013	S536	S536	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.17;3.33333;174.7873152;55;54.12;3.5;153.153;105.6;15.84876246624;4.91;0;30.94994179728;12.6;0;764.42;240.84136606204	33	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260194	4292398798	42498998	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Statin	NCIT:C61612;CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S54	S54	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	11.9;1.5015;156.2258304;72;91.8918;81.4;37.82770664112;0.99;18.68957838;3.92;0.4;45.50097469576	21.1	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260195	2739388862	27122662	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S550	S550	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.29;1.02102;186.0015456;89;126.98;3.3;162.162;129.8;13.75552968768;12.36;0;35.73447386256;57.7;1.1;1319.38;261.23835471876	22.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260276	996047040	10375490	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin,Therapeutic Insulin	CHEBI:87631;NCIT:C2271	Yes	cMD	10:43.0
KarlssonFH_2013	S563	S563	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Finland	NCIT:C16584	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	4.69;5.16516;151.5854592;68;16.4;0.1;236.0358;138.6;20.48377790448;1.33;0;22.72652731008;36.6;0.7;1798.27;180.4348996556	29.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260202	3464254550	34299550	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin,Therapeutic Insulin	NCIT:C61612;NCIT:C2271	Yes	cMD	10:43.0
KarlssonFH_2013	S577	S577	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	8.67;3.33333;248.6465568;67;62.57;1.1;117.117;94.6;24.6702434616;0.38;6.65;59.806650816;31.4;0.2;890.01;135.71842452356	26.6	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260203	2859467358	28311558	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S587	S587	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;Not applicable;mg/dL	0.36036;137.6643456;63;84.6846;143;30.94994179728;1.06;17.79247861776;2.2;51.77697120552	27.5	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260206	2766721482	27393282	23719380	IlluminaHiSeq	Female	NCIT:C16576	Therapeutic Insulin	NCIT:C2271	Yes	cMD	10:43.0
KarlssonFH_2013	S59	S59	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	19;1.23123;208.816704;60;89.17;0.4;97.2972;77;49.3404869232;0.34;0;26.165409732;3.58;0.6;675.62;61.19096597016	18.2	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260209	2516923030	24920030	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S598	S598	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	12.3;3.42342;149.6519712;69;82.18;3.3;126.126;88;25.71685985088;3.29;0;25.56734322384;53.6;0.4;822.75;75.31195811712	29.9	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260210	3514734754	34799354	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S600	S600	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;mg/dL;mmol/mol;mg/dL;mg/L;mg/dL;ug/L;Not applicable;mg/dL	12.1;2.82282;159.3194112;76;115.3152;81.4;23.32459381824;1.53;30.20235866208;21.4;1.2;94.1399476464	24.8	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260211	3105065624	30743224	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S602	S602	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	6.43;4.74474;189.8685216;61;131.9;0.1;117.117;92.4;20.03522802336;3.54;1.74;44.55595485792;34.7;0.6;765.62;102.76944284732	30	Paolo_Manghi,Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR275252	3603680606	35680006	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S640	S640	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	14.4;2.25225;186.0015456;69;55.88;1;118.9188;74.8;41.41610569008;0.71;1.02;24.81976008864;13.2;0.6;567.92;65.89796335248	25	Paolo_Manghi,Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260220	2557243442	25319242	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S655	S655	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.7;1.65165;208.4300064;72;120.59;0.3;102.7026;83.6;26.76347624016;3.52;1.65;47.99483727984;15.1;0;464.81;69.03596160736	27.1	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260223	1266123274	12535874	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
KarlssonFH_2013	S80	S80	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin Measurement;C-peptide Measurement;Cholesterol Measurement;Creatinine Measurement;Fibroblast Growth Factor 19 Measurement;Glucagon-like Peptide-1 Measurement;Glucose Measurement;Glycosylated Hemoglobin Measurement;High Density Lipoprotein Cholesterol Measurement;High Sensitivity C-Reactive Protein Measurement;Interleukin 1 Measurement;LDL Particles Measurement;Leptin Measurement;Glutamate decarboxylase 65 antibody Measurement;Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement;Triglyceride Measurement	ug/mL;ng/ml;mg/dL;umol/L;pg/ml;pmol/L;mg/dL;mmol/mol;mg/dL;mg/L;pg/ml;mg/dL;ug/L;Not applicable;ng/ml;mg/dL	11.3;2.43243;209.2034016;69;100.14;1.1;106.3062;77;24.07217695344;0.83;0.14;47.0977375176;28.2;0.4;1163.37;112.96793717568	27.5	Paolo_Manghi,Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260225	1880622222	18620022	23719380	IlluminaHiSeq	Female	NCIT:C16576	Statin	CHEBI:87631	Yes	cMD	10:43.0
